Differential Expression of MED12-Associated Coding RNA Transcripts in Uterine Leiomyomas

Area of Science:

• Genetics
• Molecular Biology
• Gynecologic Oncology

Background:

• Somatic MED12 mutations are frequent in uterine leiomyomas, implicating them in pathogenesis.
• Understanding the molecular consequences of these mutations is key to leiomyoma research.

Purpose of the Study:

• To investigate the coding RNA transcript expression profile in leiomyomas with and without MED12 mutations.
• To compare these profiles with matched myometrium tissue.

Main Methods:

• Next-generation RNA sequencing (NGS) was employed to profile RNA transcripts.
• Differential gene expression analysis was performed on 19 paired leiomyoma and myometrium samples.

Main Results:

• 394 genes showed differential and aberrant expression exclusively in mutated leiomyomas, primarily involved in extracellular constituent regulation.
• Tumors with MED12 mutations exhibited a greater magnitude of gene expression change compared to non-mutated tumors.
• Significant transcriptome differences were observed in myometrium from mutated versus non-mutated specimens, notably in genes responding to oxygen-containing compounds.

Conclusions:

• MED12 mutations profoundly influence gene expression in both leiomyoma tissue and the myometrium.
• These alterations likely affect leiomyoma characteristics and growth potential.